BioGaia AB (publ) BioGaia AB (publ)

BioGaia AB (publ)

BIOG-B

Classement en actions #7793
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
Prix de l'action
$13.94
Capitalisation boursière
$1.37B
Changement (1 jour)
0.16%
Changement (1 an)
23.91%
Pays
SE
Échange BioGaia AB (publ) (BIOG-B)

Catégorie

Healthcare
Historique du rendement du dividende pour BioGaia AB (publ) (BIOG-B)
Le rendement du dividende (TTM) de BioGaia AB (publ) (symbole boursier : BIOG-B) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de BioGaia AB (publ) (BIOG-B) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes